Microsoft reenters healthcare market; Trump accuses Cummings of avoiding drug-pricing meeting; Trump says ACA replacement plan to be unveiled in March
Pharmaceutical and healthcare companies use a mix of corporate and brand accounts on Instagram, and some are turning to celebrity influencers.
The Kim Kardashian debacle aside, what makes the platform so potentially valuable to pharma and healthcare marketers is its visual story-telling capability.
A bout with Lyme disease led Yee to found a company that helps patients measure and track their breathing patterns.
Merck and Aetna partner in value-based drug pricing; data scientists rising in the biopharma ranks; Japanese pharma leads digital health innovation
Transportation barriers can limit patient involvement in clinical trials.
Novartis forecasts slower growth in 2017; Actelion reports trial failure for PAH drug; HHS nominee Tom Price denies conflict of interest claims
Rep. Price to answer questions at confirmation hearing; 22 drugmakers invest in fighting disease in poor countries; FDA approves generic of Jazz's Xyrem
There are dozens of players, including leaders like IBM Watson Health and Verily as well as smaller concerns, lining up to sell pharma access to some sort of data solution.
Nothing is more personal than an individual's health; the technology that will prove most effective will be solutions that are personal.
Illumina and IBM enter DNA sequencing partnership; J&J to outline price increases in new report; Egalet's opioid Arymo ER gets FDA approval
Read more to learn what Startup Health's Unity Stoakes and UCB's Greg Cohen, and others have to say about the latest trends for 2017.
Data scientists are a new kind of insight and analytics professional showing up in the biopharma ranks.
The first step is to seek leadership support, she says.
This month we will debut a restyled MM&M logo on our website, in a mobile-friendly, redesigned email newsletter, and on the cover of our magazine.
We at MM&M found out just how much pharma marketers love a list. Here, read through the year's most-read technology stories.
Lilly to offer discounts for insulin products; Trump reportedly considering Scott Gottlieb to lead FDA; three execs depart Valeant
Adherence is one of the biggest challenges physicians face in diabetes management.
It is also seeking industry input for a new category of honoree, the Top 10 Innovation Catalysts.
Pharma can reach physicians within the EHR, but they must send the right message at the right time, she said at an MM&M event.
The drugmaker is using Propeller Health's sensor technology to find new ways to improve adherence in clinical studies.
The search-engine giant says that one in 20 online searches are related to healthcare, and more users are using mobile to consume media.
How VR, nanotechnology, and 3D printing could improve the value of healthcare; 100 experimental therapies in late-stage clinical trials; Kite Pharma plans "controlled" launch of CAR-T therapy
Companies such as Eli Lilly and Medtronic have launched branded apps for their products, but experts say they don't make sense for all medicines.
A new survey found that U.S. pharma marketers prefer using social media and mobile apps to reach healthcare providers.
Former Valeant and Philidor execs arrested; at least 1 million enroll in 2017 exchange plans; mobile game helps scientists study dementia
The programmatic advertising technology company also hired Chris Neuner as SVP and GM of digital health.
As digital-health funding increases, here's how VR, nanotechnology, and 3D printing could potentially improve the value of healthcare.
While VR is only just getting started, some marketers are already embracing its potential to offer an immersive experience for far-off future campaigns.
It's becoming less and less likely that an in-person physician/sales rep interaction will take place at the healthcare provider's office.